Journal article
Diagnostic criteria for vascular cognitive disorders: a VASCOG statement
Alzheimer disease and associated disorders, Vol.28(3), pp.206-218
2014
DOI: 10.1097/WAD.0000000000000034
PMCID: PMC4139434
PMID: 24632990
Abstract
Background: Several sets of diagnostic criteria have been published for vascular dementia since the 1960s. The continuing ambiguity in vascular dementia definition warrants a critical reexamination.
Methods: Participants at a special symposium of the International Society for Vascular Behavioral and Cognitive Disorders (VASCOG) in 2009 critiqued the current criteria. They drafted a proposal for a new set of criteria, later reviewed through multiple drafts by the group, including additional experts and the members of the Neurocognitive Disorders Work Group of the fifth revision of Diagnostic and Statistical Manual (DSM-5) Task Force.
Results: Cognitive disorders of vascular etiology are a heterogeneous group of disorders with diverse pathologies and clinical manifestations, discussed broadly under the rubric of vascular cognitive disorders (VCD). The continuum of vascular cognitive impairment is recognized by the categories of Mild Vascular Cognitive Disorder, and Vascular Dementia or Major Vascular Cognitive Disorder. Diagnostic thresholds are defined. Clinical and neuroimaging criteria are proposed for establishing vascular etiology. Subtypes of VCD are described, and the frequent cooccurrence of Alzheimer disease pathology emphasized.
Conclusions: The proposed criteria for VCD provide a coherent approach to the diagnosis of this diverse group of disorders, with a view to stimulating clinical and pathologic validation studies. These criteria can be harmonized with the DSM-5 criteria such that an international consensus on the criteria for VCD may be achieved.
Details
- Title: Subtitle
- Diagnostic criteria for vascular cognitive disorders: a VASCOG statement
- Creators
- Perminder Sachdev - Neuropsychiatry, School of Psychiatry, University of New South Wales, Sydney, AustraliaRaj Kalaria - Cerebrovascular Pathology (Neuropathology), Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle-Upon-Tyne NE4 5PL, United KingdomJohn O’Brien - Old Age Psychiatry, Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle NE4 5PL, UKIngmar Skoog - Social Psychiatry and Epidemiology, Neuropsykiatri SU/M�lndal, Wallinsgatan 6, 431 41 M�lndal, SwedenSuvarna Alladi - Department of Neurology, Nizam's Institute of Medical Sciences, Hyderabad, IndiaSandra E Black - Neurology, University of Toronto, Sunnybrook Health Sciences Centre, Room A421- 2075 Bayview Avenue, Toronto, ON M4N 3M5Deborah Blacker - Psychiatry, Harvard Medical School, Boston Mass., USADan Blazer - Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27710, USAChristopher Chen - Memory Aging and Cognition Centre, National University Health System, Kent Ridge Road, Singapore 119228Helena Chui - Department of Neurology, University of Southern California, Keck School of Medicine, Los Angeles, CA, USAMary Ganguli - Psychiatry, Neurology, and Epidemiology, University of Pittsburgh School of Medicine and Graduate School of Public Health, Pittsburgh, USAKurt Jellinger - Institute of Clinical Neurobiology, Kenyongasse 18; A-1070 ViennaDilip V Jeste - Estelle and Edgar Levi Chair in Aging and Distinguished Professor of Psychiatry and Neurosciences, University of California, San Diego, California 92093, USAFlorence Pasquier - University Lille Nord de France UDSL and Memory Clinic, CHU, 59000 Lille, FranceJane Paulsen - Psychiatry, Neurology, Psychology and Neurosciences, The Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USANiels Prins - Alzheimer Centre and Department of Neurology, VU University Medical Centre, Amsterdam, the NetherlandsKenneth Rockwood - Medicine (Geriatric Medicine & Neurology) and Kathryn Allen Weldon Professor of Alzheimer Research, Dalhousie University Halifax NS Canada B3H 2E1Gustavo Roman - Jack S. Blanton Distinguished Chair, Director Nantz National Alzheimer Center, Methodist Neurological Institute, 6560 Fannin Street, Suite 802, Houston, Texas 77030, USAPhilip Scheltens - Alzheimer Centre and Department of Neurology, VU University Medical Centre, Amsterdam, the NetherlandsInternationlal Society for Vascular Behavioral and Cognitive Disorders
- Resource Type
- Journal article
- Publication Details
- Alzheimer disease and associated disorders, Vol.28(3), pp.206-218
- DOI
- 10.1097/WAD.0000000000000034
- PMID
- 24632990
- PMCID
- PMC4139434
- NLM abbreviation
- Alzheimer Dis Assoc Disord
- ISSN
- 0893-0341
- eISSN
- 1546-4156
- Language
- English
- Date published
- 2014
- Academic Unit
- Psychiatry; Psychological and Brain Sciences
- Record Identifier
- 9984083292502771
Metrics
27 Record Views